New, life-changing treatments are urgently needed for people with progressive MS. A major obstacle is the lack of a quick way to detect whether a therapy is working, since progression can occur slowly. The search has been on for biomarkers that can predict disease activity and detect response to therapy.
In this webcast from The International Progressive MS Alliance, learn how using artificial intelligence in MRIs and routine blood tests could result in biomarkers to predict disability and disease progression. New biomarkers would speed clinical trials of new treatments.
To view the languages available and change the subtitles, select the video settings in the bottom right corner.
If you have any questions or feedback on our resource, please contact us on our website.Contact us
Help us add subtitles to this video
We're always looking for member organisations to add translated subtitles to video resources, so they can be accessible to people in different countries around the world. Not a member? If we don't have a member that speaks your language and you would like to add subtitles to this resource, we'd love to hear from you to discuss options and explore what's possible!Contact us